It is preferable to use well-established markers for drugs. For example, the dissolution test should be used systematically for drugs that generally have dissolution problems [20]. In addition, titration of degradation products is very important in the case of tetracydine, the titration of active substances is recommended for antibiotics and products with a narrow therapeutic range. For large quantities of solution, the search for endotoxins, the cause of pyrogens, will give better information than a test for sterility, which has littie chance of being positive. 1.1.3. Verification of similarity between the manufacturer's file and the quality of the product In association with the manufacturer's file, quality control is one of the methods to ensure conformity of the product with the manufacturer's reference. 1.2. Limits Limits of pharmacopoeias Pharmacopoeias were not published with a view to making quality control of drugs listed in international tenders. The European and French Pharmacopoeias list control methods for.
If gyne-lotrimin is taken with certain other drugs, the effects of either could be increased, decreased, or altered.
Infections, favored by intrauterine or post-birth transmission10, 16. Oral candidiasis and parotid enlargement are considered to be important signs of disease progression, guiding decisions during the treatment of children with AIDS2, 3, 8, 9, In the present study, the frequency of yeasts, their characteristics and levels of proteinase and phospholipase production in children with AIDS were evaluated and compared to those of 30 clinically healthy control individuals without associated risk factors. The susceptibility of C. albicans to five antifungal agents was also analyzed using a commercial kit E-Test.
`Thinning' of viscous airway mucus with mucolytic drugs is one way of improving clearance, both by cough and by mucociliary transport. However, although numerous mucolytic drugs are available worldwide, their effectiveness in treatment of stable COPD has not been established.[193] Consequently, they are not generally recommended in current guidelines on management.[2] However, two rigourous meta-analyses demonstrate that treatment for at least two months with mucolytic drugs, especially N-acetylcysteine, reduces exacerbations and days of illness.[182, 194] Cost-effective treatment would be in severe patients.[195] However, it is un Adis Data Information BV 2003. All rights reserved, because lotrimin af spray.
How effective and safe are antiplatelet drugs in preventing preeclampsia and its consequences?.
INGREDIENT 31. 32. 33. pseudoephedrine hydrochloride NDA ; triprolidine hydrochloride NDA ; oxymetazoline hydrochloride NDA ; pyrantel pamoate povidone iodine sponge NDA ; diphenhydramine hydrochloride dexbrompheniramine maleate NDA ; chlophedianol hydrochloride doxylamine succinate loperamide NDA ; hydrogenated soybean oil and lecithin ibuprofen, pseudoephedrine HCl NDA ; * clotrimazole NDA ; permethrin NDA ; clotrimazole NDA ; miconazole nitrate hydrocortisone hydrocortisone acetate clemastine fumarate NDA ; clemastine fumarate in combination with phenylpropanolamine HCl NDA ; dexchlorpheniramine maleate naproxen sodium NDA ; pheniramine maleate with naphazoline HCl NDA ; antazoline phosphate with naphazoline HCl NDA ; famotidine NDA ; ibuprofen suspension 100mg 5ml for pediatric use NDA ; cimetidine NDA ; ketoprofen NDA ; ranitidine NDA ; butoconazole nitrate NDA ; minoxidil NDA ; ADULT DOSAGE 120 mg 12 hours oral timed-release ; 5 mg 12 hours 0.025% solution drops topical ; 11 mg kg of body weight maximum dose 1 g oral ; 10% new dosage form ; 25-50 mg 4-6 hours oral ; 3 mg 6-8 hours oral ; 25 mg 6-8 hours oral ; 7.5 mg - 12.5 mg. 4-6 hours oral ; 4 mg, then 2 mg, 8 mg day oral ; 12.4 g powder in 2-3 oz water 20 minutes before gall bladder x-rays 200 mg ibuprofen, 30 mg pseudoephedrine HCl 1% lotion and cream 2 times daily 1% cream rinse 1% cream & 100 mg inserts 2.0% cream and 100 mg inserts Above 0.50% to 1.0% Above 0.50% to 1.0% 1.34 mg 12 hours 1.34 mg 12 hours 2 mg 4-6 hours oral ; 220 mg 4-6 hours oral ; 0.3%; 0.025% in solution 0.5%; in solution 10 mg, up to 20 mg day 7.5 mg kg up to 4 times a day 200 mg up to twice per day 12.5 mg every 4 to 6 hours 75 mg up to twice per day 2.0% cream and applicators 3 days ; 2.0% topical solution PRODUCT CATEGORY nasal decongestant antihistamine occular vasoconstrictor anthelmintic antimicrobial antiemetic antihistamine antitussive antihistamine antidiarrheal cholecystokinetic analgesic decongestant antifungal pediculicide head lice ; anticandidal anticandidal antipruritic anti-itch ; antipruritic anti-itch ; antihistamine antihistamine decongestant antihistamine internal analgesic antipyretic ophthalmic antihistamine decongestant ophthalmic antihistamine decongestant acid reducer internal analgesic antipyretic acid reducer internal analgesic acid reducer anticandidal hair grower DATE OF OTC APPROVAL June 17, 1985 June 17, 1985 May 30, 1986 August 1, 1986 January 7, 1987 April 30, 1987 May 22, 1987 August 12, 1987 August 24, 1987 March 3, 1988 February 28, 1989 September 19, 1989 October 23, 1989 May 5, 1990 November 30, 1990 March 13, 1991 August 30, 1991 + August 30, 1991 + August 21, 1992 August 21, 1992 December 9, 1992 January 11, 1994 June 8, 1994 July 11, 1994 April 28, 1995 June 16, 1995 June 19, 1995 October 16, 1995 December 19, 1995 December 26, 1995 February 9, 1996 Tavist-1 Sandoz Consumer ; Tavist-D Sandoz Consumer ; last monograph switch ; Aleve Bayer ; Naphcon A Alcon ; , Opcon A Bausch & Lomb ; Ocuhist Akorn ; Vasocon A Ciba ; Pepcid AC J&JMerck ; Children's Motrin McNeil Consumer ; Tagamet HB SmithKline ; Orudis KT Whitehall-Robins ; , Actron Bayer ; Zantac 75 Warner Wellcome ; Femstat 3 Procter & Gamble ; Rogaine Pharmacia & Upjohn ; Nyquil Procter & Gamble ; Imodium A-D Johnson & Johnson ; Liposperse Merck ; Advil Cold and Sinus Wyeth ; Potrimin AF Schering ; Nix Warner-Lambert ; Gyne-Lotrimin Schering ; , Mycelex-7 Miles ; Monistat 7 Ortho ; Drixoral Plus Schering ; PRODUCT EXAMPLES Actifed Warner-Lambert ; Actifed 12-hour Capsules Warner-Lambert ; Ocuclear Schering ; Pin-X Effcon ; E-Z Scrub 241 Deseret and metrogel.
Lotrimin for women
Toxic shock nature of lotrimin are also pentasa new virus procrit discussed.
Testing for sexually transmitted diseases in public health laboratories in 200 sex transm dis 2007; - this article was provided by centers for disease control and prevention and
mobic, for instance, lotrimin tablets.
To ensure administration of the proper dose of the drug, the patient should be instructed by the physician or other health professional in the proper use of the inhalation aerosol.
7. Agrawal N, Maine M, Chiriva-Internati M et al. Temporal acceleration of the human papillomavirus life cycle by adeno-associated virus AAV ; type 2 superinfection in natural host tissue. Virology 2002; 297: 203-210 and
moduretic.
Noninvasive ECG Findings The ECG findings of the 3 groups are shown in Table 2. There were no significant differences in the number of subjects that satisfied the criteria for LVSA-ECG, and TWA abnormality or QT dispersions between the 3 groups. However, the value of high frequency power of HRV in the calcium antagonist group 3.4 2.5 ms2 ; was significantly p 0.05 ; lower than those of the nitrates group 5.0 1.8 ms2 ; and -blocker group 5.3 3.1 ms2 ; , although all 3 values were within the normal range. There were no significant differences in LF HF ratio between the 3 groups. Also, there were no significant differences in TWA among the 3 groups; all 3 groups had a TWA value of about 2.4 mV. The QTd value of the -blocker group 78 42 ms ; was longer than those of the calcium antagonist group 54 27ms ; and nitrate group 63 39 ms ; , but differences in QTd among the 3 groups were not statistically significant. The serum NE level of the calcium antagonist group was 621 341 pg ml, which was significantly higher than those of the other 2 groups nitrate group, 461 273 pg ml; -blocker group, 450 273 pg ml.
Clinical research has also shown the increasingly popular herbal remedy st and nordette.
Results The results of the cost-utility analysis are shown in Table II. The base-case analysis showed that the hysterectomy group was the most effective 4.725 QALYs ; alternative. Compared with the least costly treatment option LNG-IUS ; , the incremental cost per additional QALY ICER ; gained by hysterectomy was USD23 500 1USD 7.8HKD ; Table III ; . Both the oral medical treatment and endometrial resection ablation groups were dominated by LNG-IUS, i.e. they were more costly with lower number of QALYs gained. One-way sensitivity analysis showed that hysterectomy remained the most effective management option with the highest QALYs gained of all the model inputs. The least costly treatment option was sensitive to the variation of the probability of need for additional surgery in the endometrial resection ablation group Figures 2 and 3.
ANTIRETROVIRALS NRTIs- abacavir Ziagen ; , abacavir lamivudine Epzicom ; , abacavir lamivudine zidovudine Trizivir ; , didanosine ddI, Videx, Videx EC ; , emtricitabine Emtriva ; , lamivudine Epivir, 3TC ; , lamivudine zidovudine Combivir ; , stavudine d4T, Zerit ; , tenofovir emtricitabine Truvada ; , zalcitabine ddC, Hivid ; , zidovudine AZT, Retrovir ; . PIs- amprenavir Agenerase ; , atazanavir Reyataz ; , fosamprenavir Lexiva ; , indinavir Crixivan ; , lopinavir ritonavir Kaletra ; , nelfinavir Viracept ; , ritonavir Norvir ; , saquinavir Fortovase, Invirase ; . NNRTIs- delavirdine Rescriptor ; , efavirenz Sustiva ; , nevirapine Viramune ; . Other- hydroxyurea Hydrea ; . Entry Inhibitorsenfuvirtide Fuzeon ; . OI DRUGS PHS "A1 OI"s- acyclovir Zovirax ; , amphotericin B Fungizone ; , azithromycin Zithromax ; , cidofovir Vistide ; , clarithromycin Biaxin ; , clindamycin phosphate Cleocin Phosphate ; , famciclovir Famvir ; , fluconazole Diflucan ; , isoniazid INH ; , itraconazole Sporonox ; , leucovorin Folinic Acid ; , pentamidine Nebupent, Pentam ; , pyrazinamide, pyrimethamine Daraprim ; , rifabutin Mycobutin ; , rifampin Rifadin, Rifater, Rimactane ; , sulfadiazine, TMP SMX Bactrim, C0-Trimoxazole, Septra, Sulfatrim ; , valacyclovir hydrochloride Valtrex ; , valganciclovir Valcyte ; . Other OIs- amoxicillin Amoxil, Trimox, Wymox ; , atovaquone Mepron ; , cephalexin monohydrate Keflex ; , ciprofloxacin Cipro ; , clindamycin HCL Cleocin HCL ; , clindamycin palmitate Cleocin pediatirc ; , clotrimazole Mycelex, Otrimin ; , dapsone DDS ; , dicloxacillin sodium Dycill, Dynapen, Pathocil ; , ethambutol Myambutol ; , ketoconazole Nizoral ; , miconazole Monistat ; , nystatin Mycostatin ; , ofloxacin Floxin ; , paromomycin sulfate Humatin ; , primaquine phosphate, streptomycin sulfate, sulfamethoxazole Gantanol, Urobak ; , terconazole Terazol 3, 7 ; , trimethoprim TMP, Proloprim, Trimpex ; . Continued and ocuflox.
Where to buy Lotrimin
Table 2. Disease progress, and treatment outcome Patient 1 Septic Y Organ failure Encephalopathic * , hepatic, renal, respiratory, DIC Encephalopathic, hepatic, renal, respiratory, DIC Encephalopathic, hepatic, renal, DIC Encephalopathic, hepatic, renal, DIC, for example, lotrimin af spray.
Buy cheap Lotrimon online
My family dr, and 2 pharmacists said not to worry about this and
oxybutynin.
Introduction General medical officers infrequently have extensive backgrounds in dermatologic conditions, and often only have a few fundamentals with which to make treatment decisions. Yet dermatologic problems are one of the most common reasons for visits to sick call in the operational environment, particularly when in hot, humid climates or shipboard. Working in conditions where cleanliness is often difficult due to limited wash facilities or water supplies makes the appearance of skin conditions a virtual certainty. The following conditions are presented in a more bulletized format as some of the more common ones encountered, important clinical diagnostic points and a general outline for treatment rather than a comprehensive treatise on dermatology. Be aware that Seabees are often more at risk because of the nature of their work and exposures to large numbers of chemicals, irritants, dust and contaminated areas. Tinea Cruris jock itch ; Expanding red plaque in the groin Confirm the diagnosis with KOH preparation Tinactin, Halotex, Ootrimin Mycelex, or Micatin applied sparingly twice daily for two weeks. Any one of these, either solution or cream may be used. Switch to boxer shorts Keep area as dry and free from friction as possible Avoid meticulous over-cleansing Monilial Interigo candidal jock itch ; Confirm the diagnosis with KOH preparation Treatment as above for tinea cruris Alternatively, use nystatin cream twice daily for 2 weeks Avoid Mycolog cream or any shotgun approach Boxer shorts Keep area as dry as possible Avoid meticulous over-cleansing.
Lotrimin drug
Maybe Central America. Low-risk areas include parts of Africa and Asia, the Caribbean, Mexico, and possibly northern South America It is unclear whether this pattern is attributable to environmental factors, genetics, or both. Family History. A family history of the disease also puts people at risk for MS, although the risk for someone inheriting all the genetic factors contributing to MS is only about 2% to 4%. Nevertheless, when siblings have the disease, they are more likely to have the same degree of severity. Among identical twins the risk is about 25% to 30 and
prednisolone.
Ascensia Breeze Glucometer Ascensia Contour Glucometer Ascensia Microfil Test Strips Ascensia Autodisc Test Strips Ascensia Microlet Lancing Device Ascensia Microlet Lancets Accu-Chek Aviva Glucometer Accu-Chek Active Glucometer Accu-Chek Advantage Glucometer Accu-Chek Compact Glucometer Accu-Chek Complete Glucometer Accu-Chek Active Test Strips Accu-Chek Advantage Test Strips Accu-Chek Aviva Test Strips Accu-Chek Comfort Curve Test Strips Accu-Chek Compact Test Strips Accu-Chek Multiclix Lancet Device Accu-Chek Multiclix Lancets Accu-Chek Softclix Lancet Device Accu-Chek Softclix Lancets Benadryl Liquid Chlorpheniramine Diphenhydramine Enteric Coated Aspirin Ergocalciferol Vitamin D ; Ferrous. Sulf. Oral Preparations Guaifenesin Hydrocortisone Cream Hydrocortisone Lotion Hydrocortisone Ointment Ibuprofen Susp. 100mg 5ml Insulin Ketostix Klerist-D, Deconamine Latex Condoms Lotrimln Mycelex Cream Lotrimin Mycelex Lotion Lotrimin Mycelex Monistat Cream Monistat Derm Monistat Fungoid Niacin Nicotine patches OTC Loratadine loratadine-D OTC Miralax OTC Prilosec: ST * , QL OTC Vitamin-S Syrup OTC Vitamins with Iron for children 12 years of age ; OTC Zaditor Plan B for 18 years of age ; Prenatal Vitamins.
It relieves pain but what sets the drug apart from other pain killers is that it is much less likely to cause severe stomach problems such as bleeding ulcers and protonix.
1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993; 270: 83-90. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994; 151: 54-61. Lue TF. Erectile dysfunction. N Engl J Med. 2000; 342: 18021813. Monga M. Sexual dysfunction in cancer patients. The Handbook of Sexual Dysfunction. 1999: 35-38. Chap 7. 5. Siegel T, Moul JW, Spevak M, et al. The development of erectile dysfunction in men treated for prostate cancer. J Urol. 2001; 165: 430-435. Sanchez-Ortiz RF, Broderick GA, Rovner ES, et al. Erectile function and quality of life after interstitial radiation therapy for prostate cancer. Int J Impot Res. 2000; S18-24. 7. Matzkin H, Kaver I, Stenger A, et al. I125 prostate brachytherapy: short-term results of the first 150 patients in Israel [Hebrew]. Harefuah. 2001; 140: 694-698, Stock RG, Kao J, Stone NN. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol. 2001; 165: 436-439. Merrick GS, Wallner K, Butler WM, et al. Short-term sexual function after prostate brachytherapy. Int J Cancer. 2001; 96: 313319. Turner SL, Adams K, Bull CA, et al. Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation. Urology. 1999; 54: 124-129. Zelefsky MJ, Wallner KE, Ling CC, et al. Comparison of the 5November December 2001, Vol. 8, No.6.
Lotrimin on line
PK groups of BHC-Pharma Dr. G. Ahr, Dr. W. Mck, Dr.H ass and colleagues and
theo-dur and
lotrimin, because lotriminn antifungal.
To clarify the underlining mechanisms and to test whether telomere length in peripheral blood lymphocytes can serve as prognostic risk marker or predictor for the outcome of depressive disorders, the project will focus on the association between telomere lengths in lymphocytes T-cells B-cells ; and their correlations with diagnostic criteria for depression, endocrine and immunological alterations, exogenic factors drug history and virus infections, e.g. Borna disease virus ; as well as morphological changes of the CNS measured by modern MRI-methods voxel based morphometry, tensor diffusion imaging etc.
Buy generic Lotrimin online
Join epinions help sign in opinion summary lo6rimin is not just for your feet and ventolin.
Should i use a combination med or treat each with a separate medication.
7 an embolectomy also may be an option for a person whose condition is stable but who shows signs of significant reduced blood flow in the pulmonary artery.
| Lotrimin medicineThe NEWSLETTER is published in an attempt to keep pharmacists and pharmacy owners informed about laws and rules relating to the practice of pharmacy in Texas. Unless otherwise noted, permission to quote from or reproduce items in this publication is granted when due acknowledgment is made. Guest articles do not necessarily express the views of the Texas State Board of Pharmacy. Comments and or suggestions should be addressed to: Julie Hildebrand Managing Editor Retta Cole Editorial Assistant Texas State Board of Pharmacy William P. Hobby Bldg., Ste. 3-600 333 Guadalupe Street Austin, Texas 78701-3943.
Renal impairment — the pharmacokinetics of symbyax has not been studied in patients with renal impairment, for example, oltrimin oral.
Lotrimin prescription
Unlike other prescription sleep medications that need to be taken in anticipation of sleep problems, zaleplon can be taken either at bedtime or later, after people have tried to fall asleep on their own, as long as they have four or more hours remaining in bed and metrogel.
|
Testing for, 16: 195 Lessina, 25: 312t LET lidocaine epinephrine tetracaine ; , 17: 209 Levlen, 25: 312t Levlite, 25: 312t Levofloxacin for acute bacterial rhinosinusitis, 9: 109, 109t, for community-acquired pneumonia, 16: 193t, 194t-195t for human and mammalian bites, 14: 167t resistance to, 9: 105 Levonorgestrel for emergency contraception, 25: 310-311, 311, oral EC options, 25: 311, 312t side effects of, 25: 313-314, 314 Levora, 25: 312t Lidocaine Xylocaine ; chemical classification of, 17: 209, 209t for epistaxis, 20: 253t for facial wound repair anesthesia, 17: 208-209 for facial wound repair sedation, 17: 209 for mandible dislocation reduction, 19: 235 for nasal foreign bodies, 20: 254 for tongue and mucosal lacerations, 19: 238 Life-threatening facial injury, 17: 202-205, 203t Linezolide, 16: 194t-195t Lip laceration repair, 19: 237-238, 237f Lisinopril Zestril, Prinivil ; , 24: 297t Liver, acute fatty, 24: 300 Liver transplant, 2: 20-22 contraindications to, 2: 20, 21t diagnoses in patients requiring, 2: 20, 21t ED evaluation, 2: 22 indications for admission of patients, 2: 22, 22t infectious complications, 2: 20-21 postoperative complications, 2: 21 procedure, 2: 20 LMA. See Laryngeal mask airway LMWH. See Low-molecular-weight heparin Local anesthetics, 17: 209, 209t Loop diuretics, 24: 297t Lo Ovral, 25: 312t Lopressor metoprolol ; for ST-elevation MI, 8: 92t, 96t usage in pregnancy, 24: 298 Loracarbef Lorabid ; for acute bacterial rhinosinusitis, 9: 109t, 110t, for acute otitis media, 20: 250t Loratadine, 9: 108t, 10: Lorazepam, 20: 251t Losartan Cozaar ; for prevention of stroke, 5: 62 usage in pregnancy, 24: 297t Lotrimin. See Clotrimazole Lower face nerve blocks, 17: 210 Low-molecular-weight heparin advantages and disadvantages of, 12: 140t for deep vein thrombosis, 12: 140, 141t.
B.M. Pharmacy Polipharm New Life Pharma Polipharm T.P. Drug T.O. Chemical GDH GPO K.B. Pharm Macrophar Modern Manu Nakorn Pattana New Life Pharma Pharmaland Pharmasant Polipharm Progress Med. Siam Bhesaj T.O. Chemical The Medic Pharm Trustman Nakorn Pattana Pharmasant Continental Pharm Pharmaland Proof.
The results showed that resting blood perfusion was higher in atrophie blanche areas than in healthy controls.
Person to contact: NHS Centre for the Evaluation of Effectiveness of Health Care CeVEAS ; Dr. Nicola Magrini, MD CeVEAS Viale Muratori 201 41100 Modena - Italy Tel + 39-059-435200 Fax + 39-059435.222 Universities Allied for Essential Medicines UAEM ; Sandeep P. Kishore, MSc 420 E 70th, Suite 10M New York, New York USA ; 10021 Tel: 917 ; 733 1973 Email: sunny.kishore gmail.
Cynt nov 20 2005, i used gyne-lotrimin and powder at night.
During 2006 the Company expanded its women's healthcare product range with the launch of a new hormone replacement product, TULITA in Hungary. The Company's exports from Hungary were expanded by the introduction of several other products including the emergency pill ESCAPELLE, the third-generation oral contraceptive MILLIGEST and the hormone replacement FEMSEVEN on new international markets. Usage of oral contraceptives within fertility age women has gradually increased in the Eastern European and CIS region, currently 3 percent in Russia, 7 percent in Romania, 11 percent in Poland, 15 percent in Slovakia, 22 percent in Hungary and 31 percent in the Czech Republic. These levels remain relatively low compared with 32 percent in Germany, 39 percent in France and 43 percent in the Netherlands. The female healthcare business was one of the drivers of the growth in the EU countries in 2006, led by increased turnover of the third and second generation oral contraceptives and the two emergency pills together with some APIs which also increased significantly. In the CIS region the emergency contraceptive POSTINOR, several third generation oral contraceptives, and gynaecological antifungals contributed most substantially to the excellent sales growth recorded. The positive performance of some recently introduced products including MILLIGEST and LINDYNETTE slightly offset a decline in sales of other gynaecological products on the Hungarian market.
Film-coated tablets Film-coated tablets Film-coated tablets Film-coated tablets Film-coated tablets Film-coated tablets Film-coated tablets Film-coated tablets Syrup Film-coated tablets Film-coated tablets Film-coated tablets Film-coated tablets Film-coated tablets Syrup Tablets Tablets Film-coated tablets Film-coated tablets Tablets Tablets Tablets Tablets Drops for children Powder for solution for intravascular, intramuscular injection and infusion Powder for solution for intravascular, intramuscular injection and infusion Powder for solution for intravascular, intramu scular injection and infusion Capsules Prolonged release capsules Amp. Drops Cream Tablets.
Marla Dubinsky, M.D., Cedars-Sinai Medical Center, Los Angeles, California, U.S.A. Jean-Pierre Hugot, M.D., Ph.D., Hopital Robert Debree, Service de Gastro-Enterologie et Nutrition Pedi atriques, Paris, France Dysplasia and Cancer Teresa Brentnall, M.D., Chair, University of Washington, Seattle, Washington, U.S.A. Steven Itzkowitz, M.D., Mount Sinai School of Medicine, New York, New York, U.S.A. Bret Lashner, M.D., Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A. Dawn Provenzale, M.D., Duke University, Durham, North Carolina, U.S.A. Robert Riddell, M.D., University of Toronto, Toronto, Ontario, Canada David Rubin, M.D., University of Chicago, Chicago, Illinois, U.S.A. Outcome Measures for Clinical Trials in Inflammatory Bowel Disease Brian Feagan, M.D., Chair, Robarts Research Institute, London, Ontario, Canada Stephen B. Hanauer, M.D., University of Chicago, Chicago, Illinois, U.S.A. William J. Sandborn, M.D., Mayo Clinic, Rochester, Minnesota, U.S.A. Medical Therapy Bruce E. Sands, M.D., M.S., Chair, Massachusetts General Hospital, Boston, Massachusetts, U.S.A. Geert D'Haens, M.D., Ph.D., University of Leuven, Belgium George Ferry, M.D., Texas Children's Hospital, Houston, Texas, U.S.A. Joshua Korzenik, M.D., Washington University, St. Louis, Missouri, U.S.A. Lloyd Mayer, M.D., Mount Sinai Medical Center, New York, New York, U.S.A. Lloyd R. Sutherland, M.D., M.S., University of Calgary, Calgary, Alberta, Canada.
